Traws Pharma Inc (NASDAQ:TRAW) price is hovering higher on current market day and jumping 200.20% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $5.02, with intraday deals fluctuating between $11.54 and $19.44. The company’s 5Y monthly beta was ticking 1.412. Taking into account the 52-week price action we note that the stock hit a 52-week high of $19.94 and 52-week low of $4.06. The stock added 234.15% on its value in the past month.
Traws Pharma Inc, which has a market valuation of $42.91 million, is expected to release its quarterly earnings report in January.
On average, analysts have forecast the company’s revenue for the quarter will hit 60k, with the likely lows of 60k and highs of 60k. The average estimate suggests sales growth for the quarter will likely rise by 7.14% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of 230k for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow 1.77% above that which the company brought in the current year earning report.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give TRAW a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that TRAW’s price is at present 178.31% off the SMA20 and 192.26% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 89.88, with weekly volatility standing at 7.36%. The indicator jumps to 7.55% when calculated based on the past 30 days. Traws Pharma Inc (NASDAQ:TRAW)’s beta value is holding at 1.12, while the average true range (ATR) indicator is currently reading 1.38.
An analysis of the Traws Pharma Inc (NASDAQ:TRAW) stock in terms of its daily trading volume indicates that the 3-month average is 11.86K. However, this figure increases on the past 10-day timeline to an average of 11500.0.
Current records show that the company has 3.03M in outstanding shares. The insiders’ percentage holdings are 24.59% of outstanding shares while the percentage share held by institutions stands at 1.35%. The stats also highlight that short interest as of 2024-10-31, stood at 7389.0 shares, which puts the short ratio at the time at 0.62. From this we can glean that short interest is 43.00 of company’s current outstanding shares. Notably, we see that shares short in October fall slightly given the previous month’s figure stood at 12839.0. But the 61.70% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
